Status:
UNKNOWN
The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Rhinitis
Nasal Obstruction
Eligibility:
All Genders
7-18 years
Phase:
PHASE4
Brief Summary
Gastroesophageal(GERD) reflux disease is a very common problem among pediatric population and has be proved to contribute in numerous otolaryngological manifestations. Trails of empirical treatment of...
Detailed Description
The proposed study is a randomized controlled trial in which children with nasal obstruction will be randomized to receive either antireflux medication lansoprazole (prevacid) and mometasone furonate ...
Eligibility Criteria
Inclusion
- 7 (seven) to 17 (seventeen) years of age.
- Nasal obstruction as main complaint.
Exclusion
- Structural cause of nasal obstruction (deviated nasal septum, adenoid hypertrophy, nasal polyps, nasal tumors)
- Received antireflux medication during the last three months.
- Acute sinusitis
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2017
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT02278081
Start Date
January 1 2015
End Date
January 1 2017
Last Update
October 29 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.